Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Many years after the first description of central pancreatectomy (CP), this procedure remains sporadically used.1 As Goudard et al2 describe, CP is associated with a high morbidity rate and a long postoperative hospital stay3 compared with distal pancreatectomy, the real surgical alternative. Another consideration is that the long-term effects of CP on pancreatic exocrine function are controversial. Evaluation of exocrine function is often subjective, especially without any formal fecal analysis; moreover, with a pancreaticogastrostomy, the distal remnant after CP may not contribute much to exocrine function.4 It is possible that CP could preserve long-term exocrine function by preserving the distal remnant, but no results from prospective randomized trials are available to answer this question.
Del Chiaro M. Are There Really Indications for Central Pancreatectomy?. JAMA Surg. 2014;149(4):364. doi:10.1001/jamasurg.2013.4166